According to several studies, women with Crohn's disease (CD) had reduced fertility, which is mostly due to voluntary decisions and reduced ovarian reserve. In our study, we aimed to compare reproductive health parameters (RHP), previous pregnancy complications and outcomes, and ovarian reserve (OR) assessed by the anti-Mullerian hormone (AMH) in CD patients with healthy controls. In CD patients, we also compared OR according to disease phenotypes. Consecutive pre-menopausal women with CD from two IBD centers were included. The control group consisted of age and BMI-matched healthy controls. We used a questionnaire that included RHP, CD phenotype, and CD activity. Serum AMH was assessed by the Elecsys AMH plus essay. We enrolled 50 patients and 56 controls with a median age of 31 years. All CD patients were in clinical remission. We observed no difference in RHP or AMH (median 2.6 vs. 2.1 ug/l, p = 0.98), or the proportion of low OR (AMH<1,77, 38 vs. 41.1 %, p=0.84). The slope of age-related decrease did not differ between the groups. The subgroup of CD patients after surgery and those older than 30 years with CD for >5years had a steeper decrease in AMH (slope -0.12 vs. -0.29, p = 0.04 and -0.31 vs. -0.2, p = 0.029). In a multivariate analysis, age was the single independent predictor of low OR (OR=1.25). In women with Crohn's disease, once the disease activity is under control, the reproductive health and ovarian reserve do not substantially differ from healthy controls.

5th Department of Internal Medicine Comenius University Faculty of Medicine University Hospital Bratislava Bratislava Slovakia

Zobrazit více v PubMed

ĎURICOVÁ D, KRÁTKA Z, BORTLIK M, SLABÁ L, STRNADOVÁ K, KOVÁŘOVÁ T, LUKAS M, PFEIFEROVÁ M. Inflammatory bowel disease has a negative impact on patients reproductive behaviour: the first multicentre survey in the Czech Republic. Gastroenterol Hepatol. 2021;75:12–19. doi: 10.48095/ccgh202112. DOI

ELLUL P, ZAMMITA SC, KATSANOS KH, CESARINI M, ALLOCCA M, DANESE S, KARATZAS P, MORENO SC, KOPYLOV U, FIORINO G, TORRES J, LOPEZ-SANROMAN A, CARUANA M, ZAMMIT L, MANTZARIS G. Perception of reproductive health in women with inflammatory bowel disease. J Crohn’s Colitis. 2016;10:886–891. doi: 10.1093/ecco-jcc/jjw011. PubMed DOI

FLEMING R, KELSEY TW, ANDERSON RA, WALLACE WH, NELSON SM. Interpreting human follicular recruitment and antimüllerian hormone concentrations throughout life. Fertil Steril. 2012;98:1097–1102. doi: 10.1016/j.fertnstert.2012.07.1114. PubMed DOI

FRÉOUR T, MIOSSEC C, BACH-NGOHOU K, DEJOIE T, FLAMANT M, MAILLARD O, DENIS MG, BARRIERE P, BRULEY DES VARANNES S, BOURREILLE A, MASSON D. Ovarian reserve in young women of reproductive age with Crohn’s disease. Inflam Bowel Dis. 2012;18:1515–1522. doi: 10.1002/ibd.21872. PubMed DOI

JACOBS MH, REUTER LM, BAKER VL, CRAIG LB, SAKKAS D, SURREY E, DOODY KJ, JUNGHEIM ES, BAYRAK AB, HUND M, VERHAGEN-KAMERBEEK WDJ, PARDUE D, BUCK K, TIMM B. A multicentre evaluation of the Elecsys(®) anti-Müllerian hormone immunoassay for prediction of antral follicle count. Reprod Biomed Online. 2019;38:845–852. doi: 10.1016/j.rbmo.2018.12.041. PubMed DOI

KANE S. Inflammatory Bowel Disease in Pregnancy. In: MAMULA P, editor. Pediatric Inflammatory Bowel Disease. Springer Science+ Bussiness Media; 2012. pp. 515–16. DOI

KUPČOVÁ V, TURECKÝ L, DETKOVÁ Z, PRÍKAZSKÁ M, KELEOVÁ A. Changes in acute phase proteins after anti-tumor necrosis factor antibody (infliximab) treatment in patients with Crohn’s disease. Physiol Res. 2003;52:89–93. PubMed

LEE S, CROWE M, SEOW CH, KOTZE PG, KAPLAN GG, METCALFE A, RICCIUTO A, BENCHIMOL EI, KUENZIG ME. The impact of surgical therapies for inflammatory bowel disease on female fertility. Cochrane Database Syst Rev. 2019;7:CD012711. doi: 10.1002/14651858.CD012711.pub2. PubMed DOI PMC

ROSENWAKS Z, REICHMAN DE. Use of antimüllerian hormone: the risks of interpreting ovarian reserve markers in isolation. Fertil Steril. 2013;99:1850. doi: 10.1016/j.fertnstert.2013.03.036. PubMed DOI

ŞENATEŞ E, ÇOLAK Y, ERDEM ED, YEŞIL A, COŞKUNPINAR E, ŞAHIN Ö, ALTUNÖZ ME, TUNCER I, KURDAŞ ÖVÜNÇ AO. Serum anti-Müllerian hormone levels are lower in reproductive-age women with Crohn’s disease compared to healthy control women. J Crohns Colitis. 2013;7:e29–34. doi: 10.1016/j.crohns.2012.03.003. PubMed DOI

ŠPROCHA B, BLEHA B, GARAJOVÁ A, PILINSKÁ V, MÉSZÁROS J, VAŇO B. In: Population Development in Regions and Districts of Slovakia Since the Beginning of the 21st Century. ŠPROCHA B, editor. INFOSTAT-Institute of Informatics and Statistics; Bratislava: 2019. p. 46.

TAVERNIER N, FUMERY M, PEYRIN-BIROULET L, COLOMBEL JF, GOWER-ROUSSEAU C. Systematic review: fertility in non-surgically treated inflammatory bowel disease. Aliment Pharmacol Ther. 2013;38:847–853. doi: 10.1111/apt.12478. PubMed DOI

TORRES J, BONOVAS S, DOHERTY G, KUCHARZIKTGISBERT JP, RAINET ADAMINA M, ARMUZZI A, BACHMANN O, BAGER P, BIANCONE L, BOKEMEYER B, BOSSUYT P, BURISCH J, COLLINS P, EL-HUSSUNA A, ELLUL P, FREI-LANTER C, FURFARO F, GINGERT C, GIONCHETTI P, GOMOLLON F, GONZÁLEZ-LORENZO M, GORDON H, HLAVATY T, JUILLERAT P, KATSANOS K, KOPYLOV U, KRUSTINS E, LYTRAS T, MAASER C, MAGRO F, KENNETH MARSHALL J, MYRELID P, PELLINO G, ROSA I, SABINO J, SAVARINO E, SPINELLI A, STASSEN L, UZZAN M, VAVRICKA S, VERSTOCKT B, WARUSAVITARNE J, ZMORA O FIORINO GIONATA ON BEHALF OF THE ECCO. ECCO Guidelines on Therapeutics in Crohn’s Disease: Medical Treatment. J Crohns Colitis. 2019;14:4–22. doi: 10.1093/ecco-jcc/jjz180. PubMed DOI

Van Der WOUDE CJ, ARDIZZONE S, BENGTSON MB, FIORINO G, FRASER G, KATSANOS K, KOLACEK S, JUILLERAT P, MULDERS AGMGJ, PEDERSEN N, SELINGER C, SEBASTIAN S, STURM A, ZELINKOVA Z, MAGRO F. The second European evidenced-based consensus on reproduction and pregnancy in inflammatory bowel disease. J Crohns Colitis. 2015;9:107–124. doi: 10.1093/ecco-jcc/jju006. PubMed DOI

ZHAO Y, CHEN B, HE Y, ZHANG S, QIU Y, FENG R, YANG H, ZENG Z, BEN-HORIN S, CHEN M, MAO R : Risk Factors associated with impaired ovarian reserve in young women of reproductive age with Crohn’s Disease. Intest Res. 2020;18:200–209. doi: 10.5217/ir.2019.00103. PubMed DOI PMC